MedTrace Logo

Mindfulness Interventions and Cutaneous T Cell Lymphoma (CTCL)

NCT03174808 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3

Last updated 2019-11-27

No results posted yet for this study

Summary

The primary objective is to assess the feasibly, adherence, and effects of mindfulness-based stress reduction (MBSR) on anxiety and health-related quality of life in adult patients with cutaneous T-cell lymphoma at the Yale Cancer Center/Smilow Cancer Hospital.

Participants will attend group sessions led by an instructor experienced in MBSR in an academic setting. The mindfulness meditation group sessions will take place at the Smilow Cancer Center at the Yale New-Haven Hospital.

Conditions

Interventions

BEHAVIORAL

Mindfulness-Based Stress Reduction (MBSR)

Participants will attend weekly 2.5-hour group sessions (of 10-14 persons) based on the standard MBSR protocol.

Sponsors & Collaborators

  • The Wallace Foundation

    collaborator OTHER

  • Yale University

    lead OTHER

Principal Investigators

  • Eugene Shapiro, MD · Yale University

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-08-20
Primary Completion
2017-10-31
Completion
2018-11-26

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03174808 on ClinicalTrials.gov